Medical Advocates
Histoplasmosis
  Drugs

 Amphotericin B
Anti-Tumor Necrosis Factor alpha
Bevacizumab
Itraconazole
Posaconazole
Ravuconazole
RTNF-alpha
ARVs


 
Histoplasmosis Main Page Main New/Noteworthy Home Page
Last Update:  May 25, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Amphotericin B
       

        Journal Papers, Abstracts, and Commentaries
 
  The lipid formulations of amphotericin B.
Herbrecht R, Natarajan-Ame S, et al.
Expert Opin Pharmacother. 2003 Aug;4(8):1277-87.
Abstract
Anti-Tumor Necrosis Factor alpha
       

        Journal Papers, Abstracts, and Commentaries
 
  Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient
from a nonendemic area.
Jain VV, Evans T, Peterson MW.  
Respir Med. 2006 Mar 16;
Abstract
Bevacizumab
       

        Journal Papers, Abstracts, and Commentaries
 
 
Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis.
Schadlu R, Blinder KJ, Shah GK, et l
Am J Ophthalmol. 2008 May;145(5):875-8.
Abstract
 

Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with
presumed ocular histoplasmosis syndrome.
Adán A, Navarro M, Casaroli-Marano RP, Ortiz S, Molina JJ. 
Graefes Arch Clin Exp Ophthalmol. 2007 Sep 5;
Abstract
Itraconazole
       

        Journal Papers, Abstracts, and Commentaries

 
Drug-drug interaction between itraconazole and efavirenz in a patient with AIDS and disseminated
histoplasmosis.
 Koo HL, Hamill RJ, Andrade RA. 
Clin Infect Dis. 2007 Sep 15;45(6):e77-9
 Abstract

Drug-Drug Interaction between Itraconazole and the Antiretroviral Drug Lopinavir/Ritonavir in
an HIV-1-Infected Patient with Disseminated Histoplasmosis.
Crommentuyn KM, Mulder JW, Sparidans RW, et al 
Clin Infect Dis. 2004 Apr 15;38(8):E73-5.
 Abstract
 
  Antigen clearance during treatment of disseminated histoplasmosis with itraconazole
versus fluconazole in patients with AIDS.
Antimicrob Agents Chemother 2002Jan;46(1):248-50
Abstract

         Conference Reports, Abstracts, and Posters

  Relevant drug-to-drug interaction between itraconazole and NNRTI in HIV-infected patients
on maintenance therapy for disseminated histoplasmosis
 Andrade R, Giordano T, Zerai T, et al
(4th IAS Conference)
 Abstract
Posaconazole
       

        Journal Papers, Abstracts, and Commentaries

 
Salvage treatment of histoplasmosis with posaconazole.
Restrepo A, Tobon A, Clark B
J Infect. 2006 Jul 4;
Abstract

A case of disseminated histoplasmosis successfully treated with the investigational
drug posaconazole.
Clark B, Foster R, Tunbridge A, Green S.
 J Infect. 2005 Oct;51(3):e177-80.
Abstract
Ravuconazole
       

        Journal Papers, Abstracts, and Commentaries

  Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
Clemons KV, Martinez M, Calderon L, Stevens DA.
Antimicrob Agents Chemother 2002 Mar;46(3):922-4
Abstract
TNF-Alpha
       

        Journal Papers, Abstracts, and Commentaries

Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy.
Wood KL, Hage CA, Knox KS,  et al.
 Am J Respir Crit Care Med. 2003 May 1;167(9):1279-82.
Abstract
ARVs
       
        Journal Papers, Abstracts, and Commentaries
 
Drug-drug interaction between itraconazole and efavirenz in a patient with AIDS and
disseminatedhistoplasmosis.
 Koo HL, Hamill RJ, Andrade RA. 
Clin Infect Dis. 2007 Sep 15;45(6):e77-9
 Abstract

Immune reconstitution inflammatory syndrome in HIV-infected patients with
disseminated histoplasmosis.
Breton G, Adle-Biassette H, Therby A, et al   
AIDS. 2006 Jan 2;20(1):119-121.
Abstract
 
         Conference Reports, Abstracts, and Posters
 
  Relevant drug-to-drug interaction between itraconazole and NNRTI in HIV-infected patients
on maintenance therapy for disseminated histoplasmosis
 Andrade R, Giordano T, Zerai T, et al
(4th IAS Conference)
 Abstract

Histoplasmosis Main Page Main New/Noteworthy Home Page

Histoplasmosis Drugs